March 9, 2007 -- A new analysis that compared 3 common treatment options for prostate cancer found a difference between them. Men who were treated with external-beam radiotherapy did not live as long ...
Discover more about how nutrition and lifestyle interventions can improve the quality of life of patients with prostate ...
The study published by Bastiaan M Privé and colleagues in The Lancet Oncology represents, to our knowledge, the first randomised phase 2 trial evaluating lutetium-177–PSMA-617 (177Lu-PSMA-617) in ...
Metformin raised the exercise-linked metabolite Lac-Phe in prostate cancer patients across disease stages and treatment ...
Women's HRT patches can treat prostate cancer just as effectively as standard hormone injections—but with fewer of the worst ...
A non-DRE, voided urine, genomic assay to diagnose prostate cancer and to assess its aggressiveness. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...
Dr. Morris then discussed the PCWG4 Rule of 5 for defining radiographic progression free survival in the post-flare period. If there are <=5 new metastases, a confirmatory scan is performed, and if ...
Johnson & Johnson (NYSE:JNJ) has entered a clinical supply agreement with GI Innovation to test a bispecific immunotherapy combination in prostate cancer. The collaboration focuses on evaluating J&J’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results